(Q35174023)

6 August 2017

1 reference

title

Retinal ganglion cells and neuroprotection for glaucoma (English)

1 reference

6 August 2017

main subject

retinal ganglion cell

1 reference

Leonard A Levin

1 reference

6 August 2017

publication date

1 April 2003

1 reference

6 August 2017

published in

Survey of Ophthalmology

1 reference

6 August 2017

volume

48 Suppl 1

1 reference

6 August 2017

page(s)

S21-4

1 reference

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

The effect of age on the nerve fiber population of the human optic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Targeting outflow facility in glaucoma management

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Relationship between intraocular pressure and preservation of visual field in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Changes in the extracellular matrix of the human optic nerve head in primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

The optic nerve head in glaucomatous optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Hydrostatic pressure stimulates synthesis of elastin in cultured optic nerve head astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

TUNEL-Positive Ganglion Cells in Human Primary Open-angle Glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

N -methyl- D -aspartate (NMDA) induced apoptosis in adult rabbit retinas

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Nitric oxide synthase in the human glaucomatous optic nerve head.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Apoptosis in retinal ganglion cell decrease in human glaucomatous eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: anti-apoptosis by alpha-2-adrenergic receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Is there a role for the immune system in glaucomatous optic neuropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

Role of alpha-2 agonists in neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

The normal human optic nerve. Axon count and axon diameter distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2803%2900007-9

7 January 2021

10.1016/S0039-6257(03)00007-9

Identifiers

DOI

1 reference

6 August 2017

1 reference